Patient advocates respond to 'Utilizing Patient Advocates…' by Feeney et al.
作者信息
Riggare Sara, Stecher Benjamin, Stamford Jon
机构信息
Uppsala University, Uppsala, Sweden.
Independent Parkinson's Patient Advocate, Sweden.
出版信息
Health Expect. 2020 Aug;23(4):972-973. doi: 10.1111/hex.13087. Epub 2020 Jun 5.
Abstract
摘要
相似文献
1
Patient advocates respond to 'Utilizing Patient Advocates…' by Feeney et al.患者权益倡导者对芬尼等人所著的《利用患者权益倡导者……》做出回应。
Health Expect. 2020 Aug;23(4):972-973. doi: 10.1111/hex.13087. Epub 2020 Jun 5.
2
Utilizing patient advocates in Parkinson's disease: A proposed framework for patient engagement and the modern metrics that can determine its success.利用帕金森病患者代言人：一种用于患者参与的拟议框架，以及可确定其成功的现代衡量标准。
Health Expect. 2020 Aug;23(4):722-730. doi: 10.1111/hex.13064. Epub 2020 May 3.
3
[Participation of patient advocates in decision-making on the regulation of medical services in Germany. The perspective of patient advocates in the Federal Joint Committee and in the Federal Office of Quality Assurance].[患者权益倡导者参与德国医疗服务监管决策。联邦联合委员会和联邦质量保证办公室中患者权益倡导者的观点]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Jan;51(1):81-8. doi: 10.1007/s00103-008-0422-z.
4
The power of the Parkinson's patient according to Tom Isaacs: a call to action.根据汤姆·艾萨克斯的观点，帕金森病患者的力量：行动呼吁。
Eur J Neurosci. 2019 Feb;49(3):304-306. doi: 10.1111/ejn.14211. Epub 2018 Nov 9.
5
Patient Advocates Collaborate to Ensure Patients Are Members of Their Own Oncology Care Teams.患者权益倡导者合作，确保患者成为自身肿瘤护理团队的成员。
J Oncol Pract. 2016 Nov;12(11):980-982. doi: 10.1200/JOP.2016.018010. Epub 2016 Oct 23.
6
Homemakers as client advocates.
Am J Nurs. 1978 Sep;78(9):1522-3.
7
Understanding advocacy practice in mental health: a multidimensional scalogram analysis of case records.理解心理健康倡导实践：案例记录的多维标度分析。
J Ment Health. 2018 Apr;27(2):127-134. doi: 10.1080/09638237.2017.1322183. Epub 2017 May 8.
8
Best practices in patient advocacy.
J AHIMA. 1998 Sep;69(8):56-60; quiz 61-2.
9
Patient researchers - the missing link?患者研究者——缺失的环节？
Nat Med. 2020 Oct;26(10):1507. doi: 10.1038/s41591-020-1080-4.
10
PAs--consumer advocates or adversaries?
Physician Assist. 1987 Apr;11(4):14-8.
引用本文的文献
1
Barriers and Facilitators to Accessing Healthcare for People With Parkinson's Disease in Latin America: A Qualitative Study.拉丁美洲帕金森病患者获得医疗保健的障碍与促进因素：一项定性研究
Health Expect. 2025 Aug;28(4):e70380. doi: 10.1111/hex.70380.
2
Inclusion in neurological research: empowering people living with neurological diseases.纳入神经学研究：增强神经疾病患者的权能。
Nat Rev Neurol. 2025 Mar;21(3):159-170. doi: 10.1038/s41582-024-01047-6. Epub 2025 Jan 7.
3
Patient Advocates for Clinical Research (PACER): A Step Toward Ethical, Relevant, and Truly Participatory Clinical Research in India.印度临床研究患者权益倡导者组织（PACER）：迈向印度伦理、相关且真正参与式临床研究的一步。
Cureus. 2024 Apr 17;16(4):e58454. doi: 10.7759/cureus.58454. eCollection 2024 Apr.
4
A rocky road but worth the drive: A longitudinal qualitative study of patient innovators and researchers cocreating research.崎岖之路但值得前行：患者创新者和研究人员共创研究的纵向定性研究。
Health Expect. 2023 Aug;26(4):1757-1767. doi: 10.1111/hex.13790. Epub 2023 Jun 9.
5
Beyond "Ensuring Understanding": Toward a Patient-Partnered Neuroethics of Brain Device Research.超越“确保理解”：迈向患者参与的脑设备研究神经伦理学
AJOB Neurosci. 2022 Oct-Dec;13(4):241-244. doi: 10.1080/21507740.2022.2126550.
6
Evaluation of patient engagement in medicine development: A multi-stakeholder framework with metrics.评估患者参与医学研发：一个带有指标的多利益相关方框架。
Health Expect. 2021 Apr;24(2):491-506. doi: 10.1111/hex.13191. Epub 2021 Feb 24.
7
"A little (PPI) MAGIC can take you a long way" : involving children and young people in research from inception of a novel medical device to multi-centre clinical trial Roald Dahl, James and the Giant Peach (1961).“一点（质子泵抑制剂）魔法就能助你走得很远”：让儿童和年轻人从新型医疗设备的构思阶段就参与到研究中，直至多中心临床试验 罗尔德·达尔，《詹姆斯与大仙桃》（1961年）
Res Involv Engagem. 2021 Jan 6;7(1):2. doi: 10.1186/s40900-020-00243-0.
8
Erratum.勘误
Health Expect. 2020 Aug;23(4):976. doi: 10.1111/hex.13128.
9
Partnering to power progress towards a paradigm shift: Response to Riggare et al.携手推动向范式转变的进步：对里加雷等人的回应
Health Expect. 2020 Aug;23(4):974-975. doi: 10.1111/hex.13126.
本文引用的文献
1
Utilizing patient advocates in Parkinson's disease: A proposed framework for patient engagement and the modern metrics that can determine its success.利用帕金森病患者代言人：一种用于患者参与的拟议框架，以及可确定其成功的现代衡量标准。
Health Expect. 2020 Aug;23(4):722-730. doi: 10.1111/hex.13064. Epub 2020 May 3.
2
Facilitating patient participation by embracing patients' preferences-A discussion.通过接受患者偏好促进患者参与——一场讨论
J Eval Clin Pract. 2019 Dec;25(6):1070-1073. doi: 10.1111/jep.13126. Epub 2019 Mar 27.
3
Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis.触发因素、促进因素和加重因素：重新定义帕金森病的发病机制。
Trends Neurosci. 2019 Jan;42(1):4-13. doi: 10.1016/j.tins.2018.09.007. Epub 2018 Oct 17.
4
In memory of Tom Isaacs: The epitomical mover and shaker.
Eur J Neurosci. 2019 Feb;49(3):303. doi: 10.1111/ejn.14205. Epub 2018 Oct 31.
5
E-patients hold key to the future of healthcare.电子患者是医疗保健未来的关键。
BMJ. 2018 Feb 26;360:k846. doi: 10.1136/bmj.k846.
6
Patient-driven N-of-1 in Parkinson's Disease. Lessons Learned from a Placebo-controlled Study of the Effect of Nicotine on Dyskinesia.帕金森病中患者驱动的单病例试验。尼古丁对运动障碍影响的安慰剂对照研究经验教训。
Methods Inf Med. 2017 Oct 24;56(99):e123-e128. doi: 10.3414/ME16-02-0040.
7
From Patient to Patient-Entrepreneur: Development of an Ostomy Bag Sensor.从患者到患者创业者：造口袋传感器的研发
Am J Gastroenterol. 2018 Jan;113(1):8-10. doi: 10.1038/ajg.2017.260. Epub 2017 Sep 5.
8
From patient centred to people powered: autonomy on the rise.从以患者为中心到以人为本：自主性在提升。
BMJ. 2015 Feb 10;350:h148. doi: 10.1136/bmj.h148.
9
What happens when patients know more than their doctors? Experiences of health interactions after diabetes patient education: a qualitative patient-led study.当患者比医生懂得更多时会发生什么？糖尿病患者教育后的健康互动体验：一项以患者为主导的定性研究。
BMJ Open. 2013 Nov 14;3(11):e003583. doi: 10.1136/bmjopen-2013-003583.
10
The individual formerly known as patient, TIFKAP.该个体曾被称为患者TIFKAP。
Minerva Med. 2011 Dec;102(6):505.
Zotero 插件